Research programme: IGF-1 receptor inhibitors - Telik

Drug Profile

Research programme: IGF-1 receptor inhibitors - Telik

Alternative Names: PQ 401

Latest Information Update: 20 Dec 2007

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Telik
  • Class Quinolines; Small molecules; Urea compounds
  • Mechanism of Action Insulin-like growth factor I inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Cancer

Most Recent Events

  • 20 Dec 2007 Discontinued - Preclinical for Cancer in USA (Intraperitoneal)
  • 08 Feb 2007 Preclinical data added to the Cancer pharmacodynamics section
  • 11 Jan 2001 Preclinical development for Cancer in USA (unspecified route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top